Cargando…

Quality of reporting of systematic reviews published in “evidence-based” Chinese journals

BACKGROUND: The number of systematic reviews (SRs)/meta-analyses (MAs) has increased dramatically in China over the past decades. However, evaluation of quality of reporting of systematic reviews published has not been undertaken. The objective of this study is to evaluate the quality of reporting o...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jin-long, Ge, Long, Ma, Ji-chun, Zeng, Qiao-ling, Yao, Lu, An, Ni, Ding, Jie-xian, Gan, Yu-hong, Tian, Jin-hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059173/
https://www.ncbi.nlm.nih.gov/pubmed/24906805
http://dx.doi.org/10.1186/2046-4053-3-58
_version_ 1782321210114179072
author Li, Jin-long
Ge, Long
Ma, Ji-chun
Zeng, Qiao-ling
Yao, Lu
An, Ni
Ding, Jie-xian
Gan, Yu-hong
Tian, Jin-hui
author_facet Li, Jin-long
Ge, Long
Ma, Ji-chun
Zeng, Qiao-ling
Yao, Lu
An, Ni
Ding, Jie-xian
Gan, Yu-hong
Tian, Jin-hui
author_sort Li, Jin-long
collection PubMed
description BACKGROUND: The number of systematic reviews (SRs)/meta-analyses (MAs) has increased dramatically in China over the past decades. However, evaluation of quality of reporting of systematic reviews published has not been undertaken. The objective of this study is to evaluate the quality of reporting of SRs/MAs assessing efficacy and/or harms of clinical interventions published in “evidence-based” Chinese journals. METHODS: Web-based database searches were conducted for the Chinese Journal of Evidence-based Medicine, the Journal of Evidence-Based Medicine, the Chinese Journal of Evidence Based Pediatrics, and the Chinese Journal of Evidence-Based Cardiovascular Medicine. SRs/MAs assessing efficacy and/or harms of clinical interventions were included. The cut-off was December 31st 2011. The PRISMA statement was applied to assess the quality of reporting. Each item was assessed as follows: ‘Yes’ for total compliance, scored ‘1’; ‘partial’ for partial compliance, scored ‘0.5’; and ‘No’ for non-compliance, scored ‘0’. The review was considered to have major flaws if it received a total score of ≤15.0, minor flaws if it received a total score of 15.5 to 21.0, and minimal flaws if it received a total score 21.5 to 27.0. Odds ratios were used for binary variables, and the mean difference was used for continuous variables. Analyses were performed using RevMan 5.0 software. RESULTS: Overall, 487 SRs/MAs were identified and assessed. The included reviews had medium quality with minor flaws based on PRISMA total scores (range: 8.5–26.0; mean: 19.6 ± 3.3). The stratified analysis showed that SRs/MAs with more than 3 authors, from a university, hospital + university cooperation, multiple affiliations (≥2), and funding have significantly higher quality of reporting of SRs/MAs; 58% of the included reviews were considered to have minor flaws (total score of 15.6 to 21.0). Only 9.6% of reviews were considered to have major flaws. Specific areas needing improvement in reporting include the abstract, protocol and registration, and characteristics of the search. CONCLUSIONS: The reporting of SRs published in “evidence-based” Chinese journals is poor and needs to be improved in order for reviews to be useful. SR authors should use the PRISMA checklist to ensure complete and accurate accounts of their SRs.
format Online
Article
Text
id pubmed-4059173
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40591732014-06-17 Quality of reporting of systematic reviews published in “evidence-based” Chinese journals Li, Jin-long Ge, Long Ma, Ji-chun Zeng, Qiao-ling Yao, Lu An, Ni Ding, Jie-xian Gan, Yu-hong Tian, Jin-hui Syst Rev Methodology BACKGROUND: The number of systematic reviews (SRs)/meta-analyses (MAs) has increased dramatically in China over the past decades. However, evaluation of quality of reporting of systematic reviews published has not been undertaken. The objective of this study is to evaluate the quality of reporting of SRs/MAs assessing efficacy and/or harms of clinical interventions published in “evidence-based” Chinese journals. METHODS: Web-based database searches were conducted for the Chinese Journal of Evidence-based Medicine, the Journal of Evidence-Based Medicine, the Chinese Journal of Evidence Based Pediatrics, and the Chinese Journal of Evidence-Based Cardiovascular Medicine. SRs/MAs assessing efficacy and/or harms of clinical interventions were included. The cut-off was December 31st 2011. The PRISMA statement was applied to assess the quality of reporting. Each item was assessed as follows: ‘Yes’ for total compliance, scored ‘1’; ‘partial’ for partial compliance, scored ‘0.5’; and ‘No’ for non-compliance, scored ‘0’. The review was considered to have major flaws if it received a total score of ≤15.0, minor flaws if it received a total score of 15.5 to 21.0, and minimal flaws if it received a total score 21.5 to 27.0. Odds ratios were used for binary variables, and the mean difference was used for continuous variables. Analyses were performed using RevMan 5.0 software. RESULTS: Overall, 487 SRs/MAs were identified and assessed. The included reviews had medium quality with minor flaws based on PRISMA total scores (range: 8.5–26.0; mean: 19.6 ± 3.3). The stratified analysis showed that SRs/MAs with more than 3 authors, from a university, hospital + university cooperation, multiple affiliations (≥2), and funding have significantly higher quality of reporting of SRs/MAs; 58% of the included reviews were considered to have minor flaws (total score of 15.6 to 21.0). Only 9.6% of reviews were considered to have major flaws. Specific areas needing improvement in reporting include the abstract, protocol and registration, and characteristics of the search. CONCLUSIONS: The reporting of SRs published in “evidence-based” Chinese journals is poor and needs to be improved in order for reviews to be useful. SR authors should use the PRISMA checklist to ensure complete and accurate accounts of their SRs. BioMed Central 2014-06-07 /pmc/articles/PMC4059173/ /pubmed/24906805 http://dx.doi.org/10.1186/2046-4053-3-58 Text en Copyright © 2014 Li et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology
Li, Jin-long
Ge, Long
Ma, Ji-chun
Zeng, Qiao-ling
Yao, Lu
An, Ni
Ding, Jie-xian
Gan, Yu-hong
Tian, Jin-hui
Quality of reporting of systematic reviews published in “evidence-based” Chinese journals
title Quality of reporting of systematic reviews published in “evidence-based” Chinese journals
title_full Quality of reporting of systematic reviews published in “evidence-based” Chinese journals
title_fullStr Quality of reporting of systematic reviews published in “evidence-based” Chinese journals
title_full_unstemmed Quality of reporting of systematic reviews published in “evidence-based” Chinese journals
title_short Quality of reporting of systematic reviews published in “evidence-based” Chinese journals
title_sort quality of reporting of systematic reviews published in “evidence-based” chinese journals
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059173/
https://www.ncbi.nlm.nih.gov/pubmed/24906805
http://dx.doi.org/10.1186/2046-4053-3-58
work_keys_str_mv AT lijinlong qualityofreportingofsystematicreviewspublishedinevidencebasedchinesejournals
AT gelong qualityofreportingofsystematicreviewspublishedinevidencebasedchinesejournals
AT majichun qualityofreportingofsystematicreviewspublishedinevidencebasedchinesejournals
AT zengqiaoling qualityofreportingofsystematicreviewspublishedinevidencebasedchinesejournals
AT yaolu qualityofreportingofsystematicreviewspublishedinevidencebasedchinesejournals
AT anni qualityofreportingofsystematicreviewspublishedinevidencebasedchinesejournals
AT dingjiexian qualityofreportingofsystematicreviewspublishedinevidencebasedchinesejournals
AT ganyuhong qualityofreportingofsystematicreviewspublishedinevidencebasedchinesejournals
AT tianjinhui qualityofreportingofsystematicreviewspublishedinevidencebasedchinesejournals